This two-volume set provides a comprehensive guide to the essential aspects of commercial biopharmaceutical manufacturing. Covering the planning, layout and operation of successful commercial manufacturing, the aim of the books is to enable innovations, new drug development, and make affordable biological drugs available to patients worldwide. This volume covers the regulatory processes involved in producing a GMP (Good Manufacturing Practice) biopharmaceutical product for commercial distribution, including areas of current GMP, registration, and legal and ethical considerations. Emerging trends in the technology and regulatory compliance are also discussed, with advice on establishing efficient manufacturing facilities. Intended for practitioners in the commercial biopharmaceutical manufacturing industry, the text is an ideal resource for practitioners looking to develop their ability to manufacture biopharmaceutical products at a large scale.

Key Features:

  • Covers the essential aspects of commercial biopharmaceutical manufacturing for industry practitioners, including the planning, layout and operation
  • Provides sufficient information for industry practitioners to establish and operate GMP (Good Manufacturing Practice) compliant manufacturing operations
  • Includes case studies and step-by-step procedures for manufacturing specific biopharmaceutical products
  • Focused exclusively on products intended for human use
  • Includes coverage of regulatory requirements, intellectual property challenges, training of manufacturing teams and issues around cost optimisation

Formato
EPUB
Protezione
DRM Free
Data di pubblicazione
31 dicembre 2021
Editore
Collezione
Numero di pagine
350
Lingua
Inglese
ePub ISBN
9780750331753
PDF ISBN
9780750331746
ISBN cartaceo
9780750331739
Dimensioni del file
7 MB
EPUB
EPUB accessibility

Funzionalità di accessibilità

  • Sommario navigabile
sottoscrivi

Chi siamo

A proposito di De Marque Lavori Contattaci Condizioni di utilizzo Politica sulla riservatezza Feedbooks.com is operated by the Diffusion Champlain SASU company